Literature DB >> 3325876

Detection of PDGF-2 homodimers in human tumor cells.

H Igarashi1, C D Rao, M Siroff, F Leal, K C Robbins, S A Aaronson.   

Abstract

The v-sis oncogene encodes a protein structurally and functionally related to human platelet-derived growth factor (PDGF). In the present studies, we show that the primary translational product of the human sis proto-oncogene is a 26-kd protein, p26c-sis. This product is processed to yield a disulfide-linked homodimer, p56c-sis, which is further processed to a 35,000-dalton dimer, p35c-sis. Like the v-sis gene product, the PDGF-2 precursor undergoes N-linked glycosylation, implying its processing through the endoplasmic reticulum. The PDGF-2 product was shown to possess functional properties of PDGF. Whereas lysates of control COS-1 cells lacked mitogenic activity, lysates of COS-1 cells transfected with a c-sis/PDGF-2 expression vector specifically stimulated DNA synthesis of quiescent fibroblasts. Moreover, this activity was completely inhibitable by PDGF antibody. Identical forms of the sis/PDGF-2 product were identified in human tumor cells that expressed c-sis/PDGF-2 transcripts. These proteins were shown to be specifically associated with the membrane component of the tumor cells and were not detectably secreted into the culture medium. These findings support the concept that expression of the sis/PDGF-2 product in human cells responsive to its proliferative actions can be an important step in the processes leading to malignancy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3325876

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors.

Authors:  T P Fleming; T Matsui; C J Molloy; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Expression and purification of biologically active v-sis/platelet-derived growth factor B protein by using a baculovirus vector system.

Authors:  N Giese; M May-Siroff; W J LaRochelle; K van Wyke Coelingh; S A Aaronson
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

3.  Immunochemical localization of the epitope for a monoclonal antibody that neutralizes human platelet-derived growth factor mitogenic activity.

Authors:  W J LaRochelle; K C Robbins; S A Aaronson
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

4.  Regulation of expression of the c-sis proto-oncogene.

Authors:  L Ratner
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

5.  The 5' untranslated sequence of the c-sis/platelet-derived growth factor 2 transcript is a potent translational inhibitor.

Authors:  C D Rao; M Pech; K C Robbins; S A Aaronson
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

6.  Growth factors derived from a human malignant glioma cell line, U-251MG.

Authors:  J Kuratsu; J E Estes; S Yokota; M S Mahaley; G Y Gillespie
Journal:  J Neurooncol       Date:  1989-09       Impact factor: 4.130

7.  A small v-sis/platelet-derived growth factor (PDGF) B-protein domain in which subtle conformational changes abrogate PDGF receptor interaction and transforming activity.

Authors:  N Giese; W J LaRochelle; M May-Siroff; K C Robbins; S A Aaronson
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

8.  Regulation of platelet-derived growth factor gene expression by transforming growth factor beta and phorbol ester in human leukemia cell lines.

Authors:  T P Mäkelä; R Alitalo; Y Paulsson; B Westermark; C H Heldin; K Alitalo
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

9.  Partially transformed, anchorage-independent human diploid fibroblasts result from overexpression of the c-sis oncogene: mitogenic activity of an apparent monomeric platelet-derived growth factor 2 species.

Authors:  C W Stevens; W H Brondyk; J A Burgess; T H Manoharan; B G Häne; W E Fahl
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

10.  Partial characterization of glioma-derived growth factor 2: a novel mitogenic activity from human cell line D-54 MG.

Authors:  E Lyon; G Y Gillespie
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.